"there is an issue that needs to be addressed in terms of the narrative the health trust tried to present and mislead the inquest and cover up what actually happened.
.
your reason has been reported to the admin.
.
.
november 2013 (16)
.
.
.
.
suven life sciences' pashamylaram facility successfully completes usfda inspection
.
october 2006 (25)
.
'indian ip and liabilities law barrier to pharma r&d investment'